Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhaled insulin.

Literature DB >> 15155479

Inhaled insulin.

Stephanie A Amiel, K George M M Alberti.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2004 PMID： 15155479 PMCID： PMC416586 DOI： 10.1136/bmj.328.7450.1215

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

13 in total

1. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

Authors: C Bradley; C Todd; T Gorton; E Symonds; A Martin; R Plowright
Journal: Qual Life Res Date: 1999 Impact factor: 4.147

2. Injection related anxiety in insulin-treated diabetes.

Authors: A Zambanini; R B Newson; M Maisey; M D Feher
Journal: Diabetes Res Clin Pract Date: 1999-12 Impact factor: 5.602

3. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.

Authors: R A Gerber; J C Cappelleri; I A Kourides; R A Gelfand
Journal: Diabetes Care Date: 2001-09 Impact factor: 19.112

4. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

Authors: L Heinemann; W Klappoth; K Rave; B Hompesch; R Linkeschowa; T Heise
Journal: Diabetes Care Date: 2000-09 Impact factor: 19.112

5. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

Authors: Joseph C Cappelleri; William T Cefalu; Julio Rosenstock; Ione A Kourides; Robert A Gerber
Journal: Clin Ther Date: 2002-04 Impact factor: 3.393

6. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.

Authors: J C Cappelleri; R A Gerber; I A Kourides; R A Gelfand
Journal: Diabetes Care Date: 2000-12 Impact factor: 19.112

Inhaled insulin.

1. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

2. Injection related anxiety in insulin-treated diabetes.

3. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.

4. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

5. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

6. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.

7. The impact of smoking on inhaled insulin.

8. Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

Review 9. Inhaled insulin in diabetes mellitus.

Review 10. Inhaled insulin for the treatment of diabetes: projects and devices.

1. Inhaled insulin: evidence based or industry driven medicine?